Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Ionis Pharmaceuticals, Inc.
With
AstraZeneca
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Aged 18 years or older
Tumors that are relapsed or refractory to at least 1 prior anti-cancer systemic therapy and for which no standard therapy exists
Expansion cohort only: Advanced lymphoma confirmed by histopathology
Measurable or evaluable disease according to RECIST for solid tumors or according to IWRC for NHL tumors
ECOG Performance Status less than or equal to 2
Life expectancy greater than 12 weeks in the opinion of the Investigator
You may not be if
Any active or uncontrolled infection
NYHA Grade II or greater congestive heart failure
History of myocardial infarction within 6 months prior to screening
Prior radiation therapy, chemotherapy, hormonal therapy, or immunotherapy within 4 weeks prior to screening or 5 half-lives of the therapy, whichever is shorter
